A prospective study was conducted at Lagos University Teaching Hospital on patients with malignancies of the head and neck region treated with external beam irradiation type and severity of hearing loss. Each patient had a preirradiation and post irradiation pure tone audiogram at 3 weeks, 8 weeks and 6 months. Following completion of radiotherapy serial post irradiation audiogram threshold was compared with pre-treatment threshold. An increase of 10 dB HL (decibel hearing level) or greater was considered significant. Radiation dose ranged from 45-55Gy in twenty to twenty-five fractions per weeks over four to five weeks treatment. Patients that received chemotherapy as adjunctive to therapy during the period of the study were excluded.A total of 40 patients (80 ears) completed the audiological follow up out of ninety four patients seen during the study period .Age ranged between 4-79 years. The tumor site distribution showed 20% in the nasopharynx, 25% in the larynx, 15% in the nose and paranasal sinuses and 10% in the parotid. 7.5% in the oral cavity and mandible respectively and 5% in the ear. Majority 33 (82.5%) were sqaumous carcinoma, 10% were sarcoma and 5% were adenocarcinoma.Pre-radiation hearing assessment revealed 62 ears (77.5%) with normal hearing, 8ears (10%) with mild SNHL and 5 ears (6.25%) with mild and moderate CHL respectively. Final post radiation hearing assessment after 6 months revealed normal hearing in 64 ears (80%), 11 ears (13.8%) with mild SNHL and 2 ears (2.5%) with moderate SNHL. 1.25% with moderate conductive hearing loss and 2 ears (2.5%) with mixed loss. Negative effect of radiotherapy post radiation was seen in 5 ears (6.25%) mainly in mandibular, parotid and ear tumours.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.